These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3423795)

  • 1. The management of superficial bladder tumours.
    Tung KH; Tan EC; Lam HS; Low CO; Foo KT; Tock EP
    Singapore Med J; 1987 Aug; 28(4):304-7. PubMed ID: 3423795
    [No Abstract]   [Full Text] [Related]  

  • 2. [Superficial papillary bladder cancer and carcinoma in situ].
    Bandhauer K; Bischof B
    Helv Chir Acta; 1985 Sep; 52(3-4):467-8. PubMed ID: 4066375
    [No Abstract]   [Full Text] [Related]  

  • 3. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy.
    Herr HW
    J Urol; 2005 Dec; 174(6):2134-7. PubMed ID: 16280743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical impact of the classification of carcinoma in situ on tumor recurrence and their clinical course in patients with bladder tumor.
    Hayakawa N; Kikuchi E; Mikami S; Matsumoto K; Miyajima A; Oya M
    Jpn J Clin Oncol; 2011 Mar; 41(3):424-9. PubMed ID: 21169349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial comment. Patients with low-grade papillary bladder tumors could be monitored safely, deferring therapy unless the recurrent tumors increased in size or number.
    Herr HW
    Urology; 2009 Jun; 73(6):1310-1. PubMed ID: 19482150
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evolution of precancerous bladder diseases during dynamic observation and treatment].
    Klimenko IA; Romanenko AM
    Urol Nefrol (Mosk); 1987; (5):23-5. PubMed ID: 3424463
    [No Abstract]   [Full Text] [Related]  

  • 7. Factors of prognostic and therapeutic significance in patients with bladder cancer.
    Batata MA; Chu FC; Hilaris BS; Kim YS; Lee MZ; Chung S; Whitmore WF
    Int J Radiat Oncol Biol Phys; 1981 May; 7(5):575-9. PubMed ID: 6792169
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of superficial tumors of the bladder with bacillus Calmette-Guérin].
    Ackermann D; Schnyder M; Bandelier D; Studer UE
    J Urol (Paris); 1986; 92(1):33-8. PubMed ID: 3722851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superficial TCC bladder cancer: the impact of tumor differentiation on recurrence, progression and survival.
    Kurth KH
    Prog Clin Biol Res; 1984; 162A():307-18. PubMed ID: 6483914
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment and outcome of intracystic papillary carcinoma of the breast.
    Harris KP; Faliakou EC; Exon DJ; Nasiri N; Sacks NP; Gui GP
    Br J Surg; 1999 Oct; 86(10):1274. PubMed ID: 10540131
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravesical administration of bacillus Calmette-Guérin in patients with recurrent superficial carcinoma of the urinary bladder: report of a prospective, randomized trial.
    Pinsky CM; Camacho FJ; Kerr D; Geller NL; Klein FA; Herr HA; Whitmore WF; Oettgen HF
    Cancer Treat Rep; 1985 Jan; 69(1):47-53. PubMed ID: 3881177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexistence of papillary and nodular carcinomas in the urinary bladder.
    Kakizoe T; Matsumoto K; Tobisu K; Takai K; Teshima S; Kishi K
    Jpn J Clin Oncol; 1987 Jun; 17(2):179-86. PubMed ID: 3613141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment and follow-up of superficial bladder cancer].
    Raitanen M
    Duodecim; 2002; 118(9):903-9. PubMed ID: 12238168
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggressive behavior of low-grade Ta papillary urothelial bladder neoplasm in a 17-year-old patient.
    Labanaris AP; Labanaris PG; Gitsos G; Kühn R; Schott GE; Zugor V
    Urology; 2007 May; 69(5):983.e1-2. PubMed ID: 17482953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Photodynamic therapy of superficial bladder cancer. An alternative to radical cystectomy?].
    Kriegmair M; Waidelich R; Baumgartner R; Lumper W; Ehsan A; Hofstetter A
    Urologe A; 1994 Jul; 33(4):276-80. PubMed ID: 7941172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
    Yumura Y; Oogo Y; Takase K; Hamano A; Yamashita Y; Noguchi S; Satomi Y
    Hinyokika Kiyo; 2004 Nov; 50(11):767-71. PubMed ID: 15628536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [BCG immunotherapy in the treatment of superficial bladder tumors].
    Samodai L; Drinóczy M; Kolozsy Z; Mohácsi L; Dauda G; Porkoláb Z
    Orv Hetil; 1986 Oct; 127(40):2441-6. PubMed ID: 3537907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.